2010
DOI: 10.1007/978-1-4419-6064-1_11
|View full text |Cite
|
Sign up to set email alerts
|

Transmission Models and Management of Lymphatic Filariasis Elimination

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0

Year Published

2010
2010
2018
2018

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 34 publications
0
10
0
Order By: Relevance
“…Many countries have made great strides, and some have stopped MDA, but no country that had ongoing transmission of LF in 2000 has been verified to have interrupted transmission of the infection using MDA [4]. Modeling is a powerful tool for decision making in infectious disease control [30], but predictions are subject to uncertainty [31]. An important uncertainty in our study concerns the efficacy of drugs.…”
Section: Discussionmentioning
confidence: 99%
“…Many countries have made great strides, and some have stopped MDA, but no country that had ongoing transmission of LF in 2000 has been verified to have interrupted transmission of the infection using MDA [4]. Modeling is a powerful tool for decision making in infectious disease control [30], but predictions are subject to uncertainty [31]. An important uncertainty in our study concerns the efficacy of drugs.…”
Section: Discussionmentioning
confidence: 99%
“…While the current WHO-led global initiative advocating the application of annual single-dose mass drug administration (MDA) for 4–6 years to eradicate the vector-borne macroparasitic disease, lymphatic filariasis (LF), from all 73 endemic countries represents one of the largest global health programs devised to reduce the burden of tropical diseases [ 1 , 2 ], a critical challenge to parasite eradication is the heterogeneous transmission of the disease across endemic regions [ 3 6 ]. We have previously shown that such environmental and geographic variability in parasite transmission between communities may reflect the impacts of significant site-specific variations in initial ecological conditions and transmission parameters [ 7 9 ]; i.e. that observed infection patterns do not merely reflect noise clouding an inherently non-spatial transmission equilibrium [ 10 ], but represent significant sensitivity to spatial and temporal variations in the key socioecological drivers of transmission across a region [ 8 , 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…While impacts of heterogeneities in ecological and environmental factors on the transmission dynamics of vector-bone parasitic diseases, including malaria, filariasis, schistosomiasis and onchocerciasis, are a topic of growing study [ 5 , 6 , 8 , 11 , 22 , 24 ], their interactions with public health interventions by contrast is only now beginning to be appreciated [ 11 , 25 28 ]. Our previous work on LF transmission heterogeneity, for example, has highlighted the complex outcomes that such interactions may have for efforts aiming to achieve the elimination of parasitic disease [ 7 9 , 11 , 17 ]. An important finding in this regard is that while heterogeneous parasite transmission dynamics across a region may reflect strong system adaptations to site-specific environmental factors, this sensitivity to one set of localized conditions may also make a locally robustly adapted parasite system particularly fragile to perturbations that may significantly alter the variables that constrain and govern the local transmission dynamics [ 11 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The first result of import is the finding that simply increasing VC coverage to 80% under existing MDA coverages will not accelerate the meeting of LF elimination at the country level (Table 5). This is unsurprising, given that insecticide bed net coverages used in the baseline simulations across the majority of IUs within the present countries were already at values as high as 60% on average; as we highlighted before [12,64,65], increasing VC coverages by moderate amounts when MDA coverages are already at moderately high levels will not lead to significant impacts on timelines to elimination due to the inherently greater impact of chemotherapy versus VC in reducing LF infection. By contrast, but for the same reason, switching to MDA based either on biannual drug delivery or annual IDA regimens significantly accelerated the achievement of parasite elimination in all countries.…”
Section: Discussionmentioning
confidence: 78%